Related Experiment Video
Updated: Aug 17, 2026

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Large practice variations in diagnosis and treatment of delayed cerebral ischemia after subarachnoid hemorrhage
Maud A Tjerkstra1, Dagmar Verbaan1, Bert A Coert1
1Department of Neurosurgery, Amsterdam Neurosciences, Amsterdam University Medical Centers, Amsterdam, the Netherlands.
Insights
Delayed cerebral ischemia (DCI) following subarachnoid hemorrhage (SAH) lacks uniform definition and treatment. This study reveals significant variations in DCI care among Dutch hospitals, highlighting the need for standardized management protocols.
Area of Science:
- Neurology
- Critical Care Medicine
- Neurosurgery
Background:
- Delayed cerebral ischemia (DCI) is a major cause of poor outcomes after subarachnoid hemorrhage (SAH).
- The pathophysiology of DCI remains poorly understood, leading to a lack of uniform definition, diagnostic tests, and evidence-based treatments.
- This knowledge gap contributes to significant variations in patient care.
Purpose of the Study:
- To investigate the variations in the definition, diagnosis, and treatment of DCI among healthcare professionals in the Netherlands.
- To identify inconsistencies in DCI management protocols across different hospitals.
Main Methods:
- A web-based survey was distributed to 314 intensivists, neurologists, and neurosurgeons across 9 Dutch hospitals.
- Responders were categorized based on their role in coordinating SAH care.
- Responses regarding definition and diagnosis were analyzed from coordinating physicians, while treatment responses included all evaluable participants.
Main Results:
- A 34% response rate (106/314) was achieved, with 79 responses used for analysis.
- Significant variability was observed: 44% of coordinating physicians required vasospasm signs for DCI diagnosis, and 51% did not rely on diagnostic test results.
- Treatment inconsistencies included 45% of responders not prescribing nimodipine continuation for patients discharged within 21 days; however, hypertension induction was common.
Conclusions:
- This study identified substantial variations in the definition, diagnosis, and treatment of DCI in the Netherlands.
- The absence of evidence-based treatments underscores the need for standardized DCI management strategies.
- Standardization of care is crucial for optimizing outcomes for patients with SAH-induced DCI.
Background:
Delayed cerebral ischemia (DCI) contributes to poor outcomes after subarachnoid hemorrhage (SAH). The pathophysiology of DCI is not fully understood, which has hindered the adoption of a uniform definition. Furthermore, a reliable diagnostic test and an effective evidence-based treatment are lacking. This could lead to variations in care.
Methods:
A web-based survey on the variations in the definition, diagnosis, and treatment of DCI was designed and sent to 314 intensivists, neurologists, and neurosurgeons of all 9 hospitals in the Netherlands who care for patients with SAH. The responders were categorized into physicians responsible for the coordination of SAH care and those who were not. For questions on the definition and diagnosis, only the responses from the coordinating physicians were evaluated. For the treatment questions, all the responses were evaluated.
Results:
The response rate was 34% (106 of 314). All 9 hospitals were represented. Of the responses, 27 did not provide answers for the definition, diagnosis, or treatment questions; 79 responses were used for analysis. Signs of vasospasm were required by 21 of the 47 coordinating physicians (44%) when considering DCI. Of the 47 coordinating physicians, 24 (51%) did not use a diagnostic test results for a positive diagnosis of DCI. When patients were discharged within 21 days, 33 of the 73 responders (45%) did not provide a prescription for nimodipine continuation. Finally, all but one hospital had treated DCI with hypertension induction.
Conclusions:
We found large variations in the definition, diagnosis, and treatment of DCI in the Netherlands. In the absence of evidence-based treatment, standardization of management seems warranted in an effort to optimize DCI care.
More Related Videos
Related Concept Videos
Stroke: Introduction and Types
Ischemic Stroke ll: Pathophysiology
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology

